Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy
Background/Aims: Angiotensin II (Ang II) has been shown to promote cardiac remodeling during the process of hypertrophy. Myosin light chain kinase (MLCK), a specific kinase for the phosphorylation of myosin light chain 2 (MLC2), plays an important role in regulating cardiac muscle contraction and hy...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-12-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/486066 |
id |
doaj-4adc3d8737fc4926b4f9e3b2d7ca50c2 |
---|---|
record_format |
Article |
spelling |
doaj-4adc3d8737fc4926b4f9e3b2d7ca50c22020-11-25T02:19:30ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782017-12-014462281229510.1159/000486066486066Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac HypertrophyShun WangMian ChengZhengqing HuShan HuQiang ZouXin LaiBeilei LiuHong JiangCongxin HuangGang WuBackground/Aims: Angiotensin II (Ang II) has been shown to promote cardiac remodeling during the process of hypertrophy. Myosin light chain kinase (MLCK), a specific kinase for the phosphorylation of myosin light chain 2 (MLC2), plays an important role in regulating cardiac muscle contraction and hypertrophy. However, whether Ang II could facilitate cardiac hypertrophy by altering the expression of MLCK remains unclear. This study aimed to investigate this effect and the underlying mechanisms. Methods: Cardiac hypertrophy was induced via pressure overload in rats, which were then evaluated via histological and biochemical measurements and echocardiography. Angiotensin-converting enzyme inhibitor (ACEI) was used to inhibit Ang II. Neonatal rat cardiomyocytes were stimulated with Ang II to induce hypertrophy and were treated with a matrix metalloproteinase 9 (MMP9) inhibitor. Myocyte hypertrophy was evaluated using immunofluorescence and qRT-PCR. Degradation of recombinant human MLCK by recombinant human MMP9 was tested using a cleavage assay. The expression levels of MLCK, MLC2, phospho-myosin light chain 2 (p-MLC2), myosin phosphatase 2 (MYPT2), and calmodulin (CaM) were measured using western blotting. Results: ACEI improved cardiac function and remodeling and increased the levels of MLCK and p-MLC2 as well as reduced the expression of MMP9 in pressure overload-induced cardiac hypertrophy. Moreover, the MMP9 inhibitor alleviated myocyte hypertrophy and upregulated the levels of MLCK and p-MLC2 in Ang II-induced cardiomyocyte hypertrophy. Recombinant human MLCK was concentration- and time-dependently degraded by recombinant human MMP9 in vitro, and this process was prevented by the MMP9 inhibitor. Conclusion: Our results suggest that Ang II is involved in the degradation of MLCK in pressure overload-induced cardiac hypertrophy and that this process was mediated by MMP9.https://www.karger.com/Article/FullText/486066Cardiac hypertrophyAngiotensin IIMyosin light chain kinaseMatrix metalloproteinase 9 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shun Wang Mian Cheng Zhengqing Hu Shan Hu Qiang Zou Xin Lai Beilei Liu Hong Jiang Congxin Huang Gang Wu |
spellingShingle |
Shun Wang Mian Cheng Zhengqing Hu Shan Hu Qiang Zou Xin Lai Beilei Liu Hong Jiang Congxin Huang Gang Wu Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy Cellular Physiology and Biochemistry Cardiac hypertrophy Angiotensin II Myosin light chain kinase Matrix metalloproteinase 9 |
author_facet |
Shun Wang Mian Cheng Zhengqing Hu Shan Hu Qiang Zou Xin Lai Beilei Liu Hong Jiang Congxin Huang Gang Wu |
author_sort |
Shun Wang |
title |
Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy |
title_short |
Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy |
title_full |
Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy |
title_fullStr |
Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy |
title_full_unstemmed |
Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy |
title_sort |
angiotensin ii facilitates matrix metalloproteinase-9-mediated myosin light chain kinase degradation in pressure overload-induced cardiac hypertrophy |
publisher |
Cell Physiol Biochem Press GmbH & Co KG |
series |
Cellular Physiology and Biochemistry |
issn |
1015-8987 1421-9778 |
publishDate |
2017-12-01 |
description |
Background/Aims: Angiotensin II (Ang II) has been shown to promote cardiac remodeling during the process of hypertrophy. Myosin light chain kinase (MLCK), a specific kinase for the phosphorylation of myosin light chain 2 (MLC2), plays an important role in regulating cardiac muscle contraction and hypertrophy. However, whether Ang II could facilitate cardiac hypertrophy by altering the expression of MLCK remains unclear. This study aimed to investigate this effect and the underlying mechanisms. Methods: Cardiac hypertrophy was induced via pressure overload in rats, which were then evaluated via histological and biochemical measurements and echocardiography. Angiotensin-converting enzyme inhibitor (ACEI) was used to inhibit Ang II. Neonatal rat cardiomyocytes were stimulated with Ang II to induce hypertrophy and were treated with a matrix metalloproteinase 9 (MMP9) inhibitor. Myocyte hypertrophy was evaluated using immunofluorescence and qRT-PCR. Degradation of recombinant human MLCK by recombinant human MMP9 was tested using a cleavage assay. The expression levels of MLCK, MLC2, phospho-myosin light chain 2 (p-MLC2), myosin phosphatase 2 (MYPT2), and calmodulin (CaM) were measured using western blotting. Results: ACEI improved cardiac function and remodeling and increased the levels of MLCK and p-MLC2 as well as reduced the expression of MMP9 in pressure overload-induced cardiac hypertrophy. Moreover, the MMP9 inhibitor alleviated myocyte hypertrophy and upregulated the levels of MLCK and p-MLC2 in Ang II-induced cardiomyocyte hypertrophy. Recombinant human MLCK was concentration- and time-dependently degraded by recombinant human MMP9 in vitro, and this process was prevented by the MMP9 inhibitor. Conclusion: Our results suggest that Ang II is involved in the degradation of MLCK in pressure overload-induced cardiac hypertrophy and that this process was mediated by MMP9. |
topic |
Cardiac hypertrophy Angiotensin II Myosin light chain kinase Matrix metalloproteinase 9 |
url |
https://www.karger.com/Article/FullText/486066 |
work_keys_str_mv |
AT shunwang angiotensiniifacilitatesmatrixmetalloproteinase9mediatedmyosinlightchainkinasedegradationinpressureoverloadinducedcardiachypertrophy AT miancheng angiotensiniifacilitatesmatrixmetalloproteinase9mediatedmyosinlightchainkinasedegradationinpressureoverloadinducedcardiachypertrophy AT zhengqinghu angiotensiniifacilitatesmatrixmetalloproteinase9mediatedmyosinlightchainkinasedegradationinpressureoverloadinducedcardiachypertrophy AT shanhu angiotensiniifacilitatesmatrixmetalloproteinase9mediatedmyosinlightchainkinasedegradationinpressureoverloadinducedcardiachypertrophy AT qiangzou angiotensiniifacilitatesmatrixmetalloproteinase9mediatedmyosinlightchainkinasedegradationinpressureoverloadinducedcardiachypertrophy AT xinlai angiotensiniifacilitatesmatrixmetalloproteinase9mediatedmyosinlightchainkinasedegradationinpressureoverloadinducedcardiachypertrophy AT beileiliu angiotensiniifacilitatesmatrixmetalloproteinase9mediatedmyosinlightchainkinasedegradationinpressureoverloadinducedcardiachypertrophy AT hongjiang angiotensiniifacilitatesmatrixmetalloproteinase9mediatedmyosinlightchainkinasedegradationinpressureoverloadinducedcardiachypertrophy AT congxinhuang angiotensiniifacilitatesmatrixmetalloproteinase9mediatedmyosinlightchainkinasedegradationinpressureoverloadinducedcardiachypertrophy AT gangwu angiotensiniifacilitatesmatrixmetalloproteinase9mediatedmyosinlightchainkinasedegradationinpressureoverloadinducedcardiachypertrophy |
_version_ |
1724876473735577600 |